Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |